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1. Introduction 
The past thirty years have witnessed a renaissance in biology as advances in technology 
contributed to discoveries at ever-greater orders of magnitude. One of the primary reasons 
for this revolution has been the advancement of technologies that allow high-throughput 
discovery and processing of data. This accomplishment has placed volumes of data in the 
realm of “discovery” science. An important point in this period came with the complete 
sequencing of several microbial genomes followed by the sequencing of the first 
multicellular organism, Caenorhabditis elegans, and eventually that of humans and various 
model organisms, such as Drosophila melanogaster. The edifice of the genetic code fell by 
wedding a biological technique developed by Sanger, known as shotgun sequencing (Sanger 
et al., 1977), with that of computational techniques utilizing high-speed computers. Without 
the advances in computer chips and processors, at a pace defined by Moore’s law (Moore, 
1965), sequencing would have been dramatically slower and would not have brought about 
the age of bioinformatics, a symbiosis of biological data, large amounts of information, and 
computer science. 
The hypothesis that gene number is related to organism complexity is quickly discarded 
when comparing Homo sapiens, which have a genome of only 3.1 billion base pairs (Olivier et 
al., 2001; Venter et al., 20010), to other organisms. Estimates for the marbled lungfish, 
Protopterus aethiopicus, suggest 133 billion base pairs (Pedersen, 1971), making it the largest 
vertebrate genome, while, to date, the lowly amoeba, Amoeba dubia, is estimated to have the 
largest genome overall at 670 billion base pairs (McGrath & Katz, 2004). However, large 
genomes may be a liability, as suggested in the plant world, where Japonica paris, which has 
a genome of approximately 150 billion base pairs (Pellicer et al., 2010), grows more slowly 
and is more sensitive to changes in the environment (Vinogradov, 2003). In vertebrates, 
there appears to be an inverse correlation between genome size and brain size (Andrews & 
Gregory, 2009), thus, complexity may lie with other factors such as epigenetics and protein 
interactions. While estimates of human gene numbers rest between 20,000 – 30,000 genes, 
these genes may encode over 500,000 proteins. Thus, the proteome of a cell can range from 
several thousand proteins in prokaryotes to over 10,000 in eukaryotes. These numbers are 
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made more daunting with the realization that approximately 80% of the proteins in a cell do 
not stand alone, but rather form complexes with other proteins. Moreover, this complexity 
increases as the proteome of a cell can change under various conditions such as stress, 
disease, cell cycle, etc.  
Unraveling the biological complexities in a cell’s fate, growth, function, death, and disease 
has led to a number of techniques to unlock the mechanisms to these processes. Among 
these advances are those that produce large amounts of data and include gene and protein 
arrays, phage displays, yeast two-hybrid screens, and coaffinity or coimmunoprecipitation 
in combination with shotgun proteomics, which utilizes mass spectrometry. Innovations in 
techniques exploiting mass spectrometry are of particular significance, as this technology 
has improved increasingly over time. With these improvements, many technologies, once 
outside the realm of anyone but experts, are now user-friendly, opening the possibilities for 
utilization by many more scientists. Consequently, these changes in technology and 
accessibility have led to the formation of large databanks curated by individuals with an 
expertise in bioinformatics. A global view of one’s own data relative to those published by 
others increases dramatically, as one begins to delve into these databases with software tools 
that retrieve large amounts of deposited data. 
A number of methods can be used to unravel protein pathways, but the starting point is 
always the wet bench experiment that will reveal the complexity of gene expression or 
protein-protein interactions. This first step is fraught with potential limitations and pitfalls 
that vary depending on the technique. However, the object is to use an approach that will 
allow for the capture of many protein-protein interactions without the inclusion of too many 
artifacts. In my lab, we have used two techniques over the last 10 years. These are the yeast 
two-hybrid system and coimmunoprecipitation in conjunction with two-dimensional gel 
electrophoresis and mass spectrometry. Both of these procedures can yield large amounts of 
viable data, which leaves one with the option of either cherry-picking specific protein 
partners or opening a whole new world, by examining the data from a global perspective 
using bioinformatics. The latter approach, also known as systems biology, examines the 
newly discovered proteins in the larger context of protein networks or interactomes. These 
discoveries are made by using large datasets readily available online with software that will 
map the many interactions once mining of these libraries is completed and integrated with 
the experimental data. Within these maps you will find single proteins, or nodes, connected 
to other proteins, via lines known as edges. In other instances, you may find clusters of 
proteins in which, for example, a central protein acts like the hub in a wheel, forming 
connections to six or more other proteins. These hubs might reveal previously unknown 
functions of your protein, since they can have important regulatory roles in the cell (Fox et 
al., 2011). Moreover, they might suggest new subcellular functions, if they are localized 
primarily to specific cellular organelles.  
In light of these challenges, this chapter will describe the use of bench experiments and 
computational techniques to determine and exploit protein-protein interactions and unravel 
their relation to protein networks and possibly newly discovered mechanisms. These 
descriptions will include coimmunoprecipitation, verification using reciprocal 
coimmunoprecipitation and RNAi, and data mining of specific databases. Their purpose is 
to provide a primer without going into specific details, since many have been described 
previously in great detail (e.g., Golemis & Adams, 2005; Harvey & Sokolowski, 2009; 
Kathiresan et al., 2009; Navaratnam, 2009). 
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2. Experimental design and use of bait proteins 
The advances in molecular biology and protein chemistry have brought a myriad of 
techniques to the forefront to study molecule-molecule interactions as investigators seek 
to wed the relationship of their molecule of interest to various mechanisms, cycles and 
diseases. Among the techniques that have evolved for such studies are yeast two-hybrid 
screening and coimmunoprecipitation/coaffinity assays. The use of one or the other 
depends on which technique will reveal the biologically relevant answer and which might 
supply the most data for obtaining large numbers of proteins to map and build networks 
or interactomes. The yeast two-hybrid system does not need expensive hardware, such as 
a mass spectrometer, it can be done in a small laboratory, while providing high-
throughput capability, and it can provide reasonably quick insights into potential binding 
sites. However, the system is used in vitro with cDNA, so any search is only as good as the 
quality of the screened cDNA, plus any validation of findings will occur in vivo, 
eventually. Coimmunoprecipitation combined with two-dimensional electrophoresis and 
mass spectrometry: allows you to pull the proteins directly from the source, since you are 
not dependent on obtaining a cDNA library; provides insights into protein complexes and 
post-translational modifications; provides amino acid sequences for potentially unknown 
proteins. However, further studies of interacting binding sites may need the yeast two-
hybrid assay or other systems in vitro. Both systems generate false positives and 
negatives. 
Yeast two-hybrid screening packages the protein of interest as cDNA in an engineered viral 
vector or plasmid, which is used to go fishing for other proteins that are all initially dressed 
as cDNA and in their own plasmid. The former is the bait, whereas the latter, known as a 
prey, consists of a known protein or a library of unknown proteins that are, again, in the 
form of cDNA (cDNA library), encoding fragments of protein derived from a tissue or 
organism of interest. In fusion with the bait or prey cDNAs are gene sequences that 
respectively encode a eukaryotic binding and activating domain. Both bait and prey can be 
mixed together in one soup, containing yeast cells that are transformed by the plasmids, so 
that many will now contain a bait and a prey cDNA. The cDNAs are incorporated into the 
cellular machinery and expressed as protein, after which the cells are plated on an agar-
based medium. If an interaction occurs between the bait and prey proteins, the activating 
and binding domains interact to form a transcription factor that initiates a reporter gene, 
thereby changing the chromatic phenotype of the yeast for visualization. The prey cDNA, 
encoding a fragment of protein, is isolated from the yeast and sequenced to identify the 
protein involved in the interaction. Typically, this procedure involves many culture plates 
since the more plates the more likely you will capture a number of different interacting 
proteins of interest. One advantage of the yeast-two hybrid system is that you can get a 
fairly quick picture of the domains of interaction between the bait and prey proteins, since 
one of the fragments pulled from the interactions likely will be a binding site. If you do not 
begin with this technique for high-throughput analyses, you can use it on a low scale for 
studying site-directed mutagenesis in a relatively quick and reliable fashion. The downside 
for the yeast two-hybrid approach is that you will have to obtain a cDNA library from your 
tissue of interest and insert the fragments into the proper plasmid. This first step can be a 
weakness, because the screening is only as good as the library and proteins that are weakly 
or indirectly associated with your protein may be lost.  
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Fig. 1. Coimmunoprecipitation uses (1) a substrate consisting of protein A- or G-coated 
beads that bind the Fc fragment of a known antibody targeting a known antigen. (2) Once 
cells are homogenized the released protein lysate is mixed either with antibody alone or 
with antibody attached to protein-coated beads. (3) The antigen serves as bait as it brings 
many protein partners (prey). (4) This immunocomplex is eluted from the beads and 
prepared for western blotting. In high-throughput experiments, western blotting is skipped 
and the protein partners are separated on a 2-D gel and prepared for mass spectrometry (see 
Fig. 2). (5) For western blotting, an antibody is used to probe the blot for a known 
coimmunoprecipitated prey (blue). The blot can also be probed for precipitated antigen, 
since the known bait interacts with itself (red). In a reciprocal coimmunoprecipitation, the 
reverse experiment is performed, because the prey will now be used to precipitate the bait.  
Coimmunoprecipitation (Figure 1) involves the use of an antibody on a substrate, with the 
antibody directed towards an antigen (the bait protein) that brings along the prey, that is, 
interacting proteins and protein complexes. The antibody also can be directed toward the 
epitope of a protein tag in fusion with a bait protein. The advantage of the technique is that 
you can fish in a protein soup made from your tissue or organism of interest and you can 
vary the antibody/antigen bait for fishing. In addition, you can pull down both direct, 
indirect, and weak interactions as these are highly relevant to building protein networks. 
The difficulty is in getting rid of interaction artifacts, so the more artifact filtering the more 
likely the interactions will be real. To support this effort, one can rely on a combination of 
centrifugation of different cellular components and using 2-D gels to better separate protein 
partners from one another. The components in the gel are then identified using MALDI 
TOF-TOF and LC-MS/MS.  
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3. Coimmunoprecipitation 
3.1 Protein tags 
The first task in setting up an experiment is to determine whether the use of cells obtained 
from conditions in vivo or in vitro are more suitable to the biological question at hand. At 
first glance, this issue may not seem relevant; however, cells obtained from conditions in 
vitro are easily accessible, allowing more freedom in the design of bait proteins and in the 
use of tags for quantification. A major part in this decision is determining which approach is 
feasible and will answer the question in a biologically relevant manner. If a system in vitro is 
chosen, there are a number of techniques that can be used, whereas the approach is more 
limited if cells are obtained from whole organisms or tissue lysates. For experiments in vitro, 
various heterologous expression systems are readily available, such as Chinese Hamster 
Ovary (CHO) and Human Embryonic Kidney (HEK) 293 cells. The increase in accessibility 
allows the use of isotope labeling of amino acids with Stable Isotope Labeling by Amino 
Acids (SILAC), Isotope-Coded Affinity Tags (ICAT), and Isobaric Tags for Relative and 
Absolute Quantitation (iTRAQ). These tags are successfully used in proteomic experiments 
involving protein-protein interactions through the differential labeling of peptides and are 
described extensively in a recent review (Vetter et al., 2009). Here, however, we will focus on 
different types of nucleotides encoding a protein tag for bait cDNA.  
The cDNA of bait proteins transfected into a cell system can be epitope tagged, using FLAG 
(DYKDDDDK), c-myc (EQKLISEEDL), hemagglutinin (HA; YPYDVPDYA), histidine 6 
(his6; HHHHHH), vesicular stomatitis virus glycoprotein (VSV-G; YTDIEMNRLGK), simian 
virus 5 (V5; GKPIPNPLLGLDST), and herpes simplex virus (HSV; QPELAPEDPED) tags, 
among others (for additional tags see Terpe, 2003). The FLAG tag is a hydrophobic octapeptide 
(Hopp et al., 1988), recognized by different anti-FLAG monoclonal antibodies (M1, M2, and 
M5), each with different binding and recognition characteristics. Typically this tag is used at 
either the N- or C-terminal ends, as is the viral hemagglutinin coat protein or HA tag. 
However, both can be used as an epitope tag within the C- and N-terminal domains, since 
tagging at the very end of either terminal may interfere with a protein-protein interaction 
(Duzhyy et al., 2005). Moreover, if the protein is a signaling protein, a tag at the N-terminus 
will be cleaved-off the main body of the protein and thus, not resolvable on a gel. These 
cleavage sites can be less than 20 amino acids from the N-terminus. HA tags are usually 
attached in multiples of two or three in fusion with a bait protein, allowing for a better 
signal during western blotting. The c-myc tag (Evan et al., 1985) is especially popular since 
there are over 150 antibodies available from different species for this particular label. In 
comparison, the advantage of using poly-His tags is that His binds to a chelating resin 
charged with metal ions such as Ni2+, Cu2+, or Zn2+ (Noronha et al., 1999; Mateo et al., 2001). 
It can be used to not only purify proteins, but also to bind the prey in a protein lysate 
poured over a bait-bound matrix in an affinity column. Once bound, the matrix-His tag can 
be disrupted and the prey eluted. In this scenario, lysates are used from whole organisms or 
tissues dissected from the organism. 
3.2 Antibodies and tissue preparation  
The technique for capturing protein partners is to coimmunoprecipitate protein-protein 
interactions using a bait antigen bound to an antibody. A second technique is to use the 
metal ion binding His tag in fusion with a bait protein, as mentioned above. Here, we will 
focus on the antibody approach, where a major hurdle is the antibody itself. These 
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complexes can vary not only in relation to the epitope (specificity) that is targeted, but also 
in relation to the affinity, which can differ by source and/or fluctuate by lot number. The 
first rule of thumb is that that not all antibodies are created equal. Before purchasing an 
antibody, check that the targeted sequence of the epitope in your protein is not similar to the 
sequence in a different antigen. While you might assume that this comparison was made 
previously, particularly if the antibody is commercially available, a quick check never hurts, 
as sequence databases are updated on a continual basis. Gene depositories are found at the 
US National Institutes of Health at http://blast.ncbi.nlm.nih.gov/Blast.cgi, the European 
Molecular Biology Laboratory Nucleotide Sequence Database in the UK at 
http://www.ebi.ac.uk/Tools/sss/psiblast/, or the DNA Data Bank of Japan at 
http://blast.ddbj.nig.ac.jp/top-e.html. However, all three form a consortium of the 
International Nucleotide Sequence Database Collaboration, so information is exchanged on 
a daily basis. When checking, be sure to contrast species differences; however, while these 
differences are not fatal, the epitope should consist of 5 – 8 amino acids that are available for 
binding following cell/tissue denaturation. Once these sequences are checked, initial tests 
using western blots are valuable to determine if the antibody recognizes the denatured 
target.  
Prior to running a coimmunoprecipitation, a necessary step is to test the chosen 
precipitating antibody, because many commercial antibodies are not tested for this use. 
Here, the second rule of thumb is that if the antibody cannot immunoprecipitate its targeted 
antigen (bait), it will be useless in coimmunoprecipitating any partners (prey). Thus, 
checking the antibody entails doing an immunoprecipitation. The procedure is similar to a 
coimmunoprecipitation, but rather than probing the western blot for antigen partners, you 
probe for the immunoprecipitated antigen. Once verified, the antibody is suitable for use in 
a coimmunoprecipitation. Additionally, immunoprecipitations are useful in other 
applications, for example, as a control with which to compare the coimmunoprecipitated 
species. In this scenario, you must be working with already identified proteins. As an 
example, use a newly discovered partner (prey), from your high-throughput experiment to 
coimmunoprecipitate the bait, while also immunoprecipitating the bait as control. Both co- 
and immunoprecipitated species should have the same weight. This step is also referred to 
as a reciprocal coimmunoprecipitation (discussed in section 3.2), since it validates the 
original bait/prey interaction. Finally, a third use for immunoprecipitation is to increase the 
quantity of the antigen for western blotting and Enhanced Chemiluminescent (ECL) 
visualization. This technique is especially useful in pulling down lowly expressed proteins. 
These techniques are useful for validation following the initial high-throughput 
experiments.  
3.3 Lysate preparation and preclearing 
Once an antibody is chosen and tested, preparation of the cells/tissues for 
coimmunoprecipitation can begin (Figure 1). A step-by-step procedure was presented 
previously (Harvey and Sokolowski, 2009), so here, we will just touch on the salient points 
and limitations. The initial preparation of the tissues for coimmunoprecipitation is critical as 
the quality of the protein lysate is important. The goal is to disrupt the tissue sufficiently 
without disrupting protein-protein interactions. Thus, lysis buffers contain anywhere from 
120 – 1000 mM NaCl (less to more disruptive) as well as detergents to release hydrophobic-
hydrophylic interactions. Among the reagents that can disrupt protein-protein interactions 
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are ionic detergents, such as sodium Deoxycholate (DOC) and Sodium Dodecyl Sulfate 
(SDS). However, nonionic detergents, such as Triton X-100, Tween20, Octyl -D-Glucoside, 
N-dodecyl-β-D-Maltoside, Brij, Cymal, Digitonin, and NP-40, are useful in maintaining 
interactions. Octyl -D-glucoside is especially helpful for releasing protein partners from 
lipid rafts, whereas n-dodecyl-β-D-maltoside isolates hydrophobic membrane proteins and 
preserves their activity. The isolation and separation of membrane proteins on a 2-D gel can 
be especially challenging. For example, our own initial studies, to cleanly separate BK 
channel partners from the membrane fraction on a 2-D gel, revealed amidosulfobetaine-14 
(ASB-14), a zwitterionic detergent, as the best candidate relative to CHAPS (zwitterionic), 
octyl β-glucoside, and n-dodecyl β-D-maltopyranoside. 
Once the tissue is dissected on ice and placed in a cold buffer with the proper protease and 
phosphatase inhibitors, any physical disruption is accomplished with pre-cooled 
equipment, on ice, and for short durations. These tissue perturbations include: mechanical 
disruption by grinding with a blade; liquid homogenization, by squeezing through a narrow 
space, as with a French press or Dounce; sonication, by using a vibrating probe to produce 
bubbles that burst and cause a sonic wave; or freeze/thaw, which bursts membranes via ice 
crystals. For minute tissues, such as the cochlea, use a 3 mm size probe to disrupt cells for 30 
sec three times with one-minute intervals for cool down. Also, a simple mortar and pestle 
can be used and obtained in many different sizes. However, there is an art to the process, 
since you will not want to over-sonicate/homogenize. Such errors are reflected in mass 
spectroscopy results, where cytoplasmic proteins appear in the membrane fraction and vice 
versa. Again, as a reminder, the tube containing the tissues is kept on ice and any ensuing 
centrifugation should be done in either a refrigerator or a cold room.  
Lysis buffers can be relatively standardized or they can vary from lab to lab with everyone 
swearing that theirs works the best. RIPA and Tris-HCl are commonly used lysis buffers 
and their ingredients can be easily found on the web with other types of buffers at sites such 
as http://www.abcam.com/index.html?pageconfig=resource&rid=11379#A1. However, 
some buffers contain metal chelating agents such as EGTA or EDTA. These chelators have 
the ability to bind or sequester metal ions, keeping them in solution and decreasing their 
activity. For example, EGTA sequesters Ca2+ and Mg2+, but has a higher affinity for Ca2+ 
than Mg2+ ions, whereas EDTA binds Fe3+, Ca2+, Pb2+, Co3+, Mn2+, and Mg2+. The choice as to 
whether you add these chelators can depend on whether the protein-protein interactions 
you are interested in are metal ion dependent. The real differences come into play when 
deciding on which protease or phosphatase inhibitors to use (Table 1). Concentrations of 
these inhibitors can vary and may depend on, for example, whether or not you are 
interested in examining phosphorylated proteins. Protease/phosphatase inhibitors should 
always be mixed on the day of the experiment, since their stability varies quite a bit. 
Pepstatin A at a working solution of 1 µg/mL is stable for about one day, whereas the stock 
solution (100 µg/mL) is stable for several months. Leupeptin at 1-2 µg/mL is stable for a 
few hours, whereas the stock solution is stable for up to six months. Aprotinin, on the other 
hand is stable for about a week at 4oC in a solution of pH 7 at a concentration of 
approximately 0.5-2 µg/mL. Moreover, microcystin-LR may be preferred in place of okadaic 
acid, as an inhibitor of protein phosphatases PP1 and PP2A, since it is more potent. The 
downside of using this inhibitor is that in the U.S., microcystin is on the government list of 
monitored reagents and, also, it is quite expensive.  
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Table 1. Protease and phosphatase inhibitors that can be used in a cocktail mixed with a 
lysis buffer for protein extraction.  
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In order to obtain the cleanest and best protein separation on your 2-D gel, a useful step is to 
separate the lysate into different cellular components via centrifugation and prior to 
preclearing. This step is practical, especially for high-throughput experiments involving 
mass spectrometry (Kathiresan et al., 2009; Harvey & Sokolowski, 2009). After clearing 
debris, nuclei, etc., separate the membrane fraction from other soluble proteins using 
ultracentrifugation, by spinning the sample at 100k x g for about an hour at 4oC. The pellet 
will contain membrane from the plasmalemma, mitochondrion, and endoplasmic reticulum, 
while the supernatant will contain any remaining soluble proteins. To obtain additional 
separation of organelles and various other cellular components, a necessary step is density 
gradient centrifugation (Huber et al., 2003). However, the initial separation of membrane 
and cytosolic components is useful for obtaining proteins that have undergone 
phosphorylation or any other changes resulting from a cell’s response to cycle, 
developmental stage, drug response, environment, disease, etc.  
Prior to preclearing and coimmunoprecipitation, a choice is made with regard to the type of 
beads to be used as the substrate for binding the antibody. These substrates include Protein 
A- or G-coated agarose, sepharose or magnetic beads. Proteins A and G bind 
immunoglobulins in the Fc regions of an antibody, thereby, leaving the Fab region free for 
antigen binding. Protein A, originally derived from Staphylococcus aureus, binds 
immunoglobulins from a number of species and has a strong affinity for mouse IgG2a, 2b, 3, 
and rabbit IgG. Protein G was originally derived from Group G streptococcus and tends to 
have an affinity for a greater number of immunoglobulins across a broader range of species 
and subclasses of IgG. Its affinity is strong for polyclonals made from cow, horse, sheep, and 
mouse IgG1. Also, Protein G has less affinity for albumin, thereby decreasing background 
and providing cleaner preparations. Protein A and G binding affinities for various species 
can be found at http://www.millipore.com/immunodetection /id3/affinitypurification. 
The question of agarose/sepharose or magnetic beads is a matter of choice, since arguments 
can be made for either one. Magnetic beads are smaller at 1 – 4 µm and provide more 
surface area per volume, fewer handling steps, faster protocol time, greater sample 
recovery, and less risk of bead inclusion in the sample. However, you need a magnetic 
separator. In the long run, there is likely not that much difference and the outcome will lie in 
performing the necessary pilot experiments. 
Once the tissue is cleared of debris and nuclei, separated into different cellular components, 
and a choice of beads is made, begin the preclearing step. Preclearing with beads involves 
reducing the proportion of proteins that may bind non-specifically to the agarose/sepharose 
beads that are used in the coimmunoprecipitation. For high-throughput experiments, where 
western blots are not used, it is essential. However, if the endgame is a western blot and 
ECL, preclear if the background masks your protein species. One limitation of preclearing is 
that you may lose signal, which is especially disadvantageous if the expression of your 
protein is low. However, signal loss can be traced by saving non-bound components during 
the procedure. For preclearing, the lysate is mixed with a small volume of coated beads so 
that any contaminating elements that increase background noise are allowed to bind over 
time, usually over 30 min at 4oC. The resultant complex of “sticky” proteins and beads are 
discarded (or saved for testing signal loss) after centrifugation and the supernatant is 
processed for coimmunoprecipitation. Preclearing is not to be confused with a bead control. 
Here, the cleared lysate is mixed with beads in the absence of antibody to form a non-
immunocomplex, which is then processed and fractionated on a gel. An additional 
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Fig. 2. Schematic of a high-throughput proteome experiment using coimmunoprecipitation, 
two-dimensional gels, and mass spectrometry. Initially, proteins are solubilized and 
separated by ultracentrifugation into membrane and cytoplasmic fractions (blue and 
yellow), which then are divided into two separate aliquots. Anti-bait antibody (Ab) with 
protein G beads (red tubes) is used to coimmunoprecipitate putative protein partners 
obtained from an organism or tissue lysate. The different subcellular fractions are probed 
with an antibody to a specific protein and the immunocomplex captured with Protein G-
coated beads. The resultant immunocomplexes are eluted, fractionated on two-dimensional 
gels, and analyzed using LC-MS/MS. Control samples consist of running membrane and 
cytoplasmic fractions: in the absence of antibody and beads (total proteome; green tubes); 
with beads alone (purple tubes); or with a nonspecific antibody and beads (purple tubes). 
approach to preclearing, but which can also be used as a negative control, is to use a non-
specific antibody. The antibody must be isotype specific, when using a monoclonal 
antibody, or source specific, when using a polyclonal antibody for coimmunoprecipitation. 
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For example, in the event that the coimmunoprecipitating antibody is a mouse monoclonal 
IgG1, then use a nonspecific mouse monoclonal IgG1. If, on the other hand, the antibody to 
be used is a rabbit polyclonal, use a non-specific rabbit polyclonal antibody. When used as a 
control, mix the precleared lysate with the non-specific antibody and beads and process for 
gel fractionation. Finally, empirically determine how much antibody to add to the lysate 
fraction or to the beads, by determining the signal to noise in your result. A good starting 
point is to begin with 5 µg of antibody and work up or down in concentration from there.  
The cells are now ready for coimmunoprecipitation for high-throughput analyses using 2-D 
gels (Figure 2). Control experiments consist of: any sticky proteins adhering to the beads 
(non-immunocomplexed protein), any proteins obtained using a non-specific antibody, and 
finally all proteins from the entire proteome of the tissue/organism. While controls may 
take more samples, they are of value for comparison purposes and troubleshooting, and for 
acceptance into high impact journals. The gel showing the total proteome is important, since 
it will provide an overall pattern of protein spots with which to compare the gel containing 
the immunocomplexed proteins. You will likely see some similar spot patterns between the 
gels if the separation is of a good quality. One question that will arise is whether to first bind 
the antibody to the beads or bind the antibody to the antigen in the lysate and then to the 
beads. One argument for binding the antibody to the beads first is that, since the beads are 
already covered with antibody, there will be a decrease in contaminant binding, and thus, a 
decrease in background. Antibody can be covalently bound to beads using Dimethyl 
Pimelimidate (DMP) Disuccinimidyl Glutarate (DSG), Disuccinimidyl Suberate (DSS), or 
Disuccinimidyl Tartrate (DST). Arguments against crosslinking include, the buildup of 
aggregates, antibodies such as monoclonals may lose their affinity, or the antibody cross-
links to the beads in the incorrect position causing hindrance to antigen binding. 
3.4 Fractionation and gel staining 
Once both immunocomplexed and non-immunocomplexed beads are washed, perform the 
elution step using equal volumes of IEF sample and elution buffers, since the proteins are 
fractionated in two dimensions. At this point there are various nuances in terms of 
technique for running a 2-D gel. Among these is a step-by-step description by Kathiresan et 
al., (2009). Here, we will suggest some of the initial troubleshooting that may be necessary 
before and/or after running a full-fledged experiment. If little is known about the proteome 
of the tissue in your experiment, it will be of value to use an Immobilized pH Gradient (IPG) 
strip with a broad pH range (e.g., pH 3 - 10). Moreover, rather than initially using strips of 
18 to 24 cm, which give a better resolution, use a 7 cm strip to get a quick representation of 
the pI ranges that you will be working with. Also, remember that the protein volume you 
can load is related to the size of the IPG strip, so that 7, 11, 17, 18, and 24 cm strips require 
volumes of 125, 185, 300, 325, and 450 µL, respectively. After separation in the first 
dimension, proteins are fractionated according to weight in the second dimension at which 
point the gel is prepared for staining. 
There are several staining methods available, assuming that a CyDye was not used, since 
this step is accomplished prior to running the gel. The choice of stain is dependent on 
whether you are interested in searching for the low hanging fruit, that is, proteins that are 
highly expressed, or you may wish to increase staining sensitivity to detect as many protein 
partners as possible. Colorimetric stains include Coomassie Brilliant Blue, which will suffice 
for the former choice, since this stain will detect in-gel protein concentrations as low as 10 
www.intechopen.com
 
Selected Works in Bioinformatics 
 
150 
ng. For more inclusive resolution of proteins you can use silver staining, which detects 
protein concentrations less than 0.25 ng. For a detection range that lies between these two 
stains, fluorescent dyes are available that detect 0.25 – 2 ng. However, all the stains have 
their advantages and limitations. Coomassie Blue has less sensitivity, but is probably the 
most compatible stain for mass spectrometry. Silver staining has greater sensitivity but is 
less compatible with mass spectrometry, because, as with Coomassie Blue, the protein must 
be destained prior to tryptic digestion. Since formaldehyde is part of the silver staining 
process, cross-linking of the protein occurs (Richert et al., 2004), thereby causing problems 
with protein extraction from the gel and interference with mass spectrometry. A few 
techniques have been suggested to circumvent this problem, including ammoniacal silver 
staining (Richert et al., 2004; Chevallet et al., 2006). Moreover, some vendors (e.g., Thermo 
Scientific Pierce) optimize their reagents to make silver staining more compatible for mass 
spectrometry. However, silver staining still remains problematic, with its poor 
reproducibility and a nonlinear dynamic range, when measuring staining intensity relative 
to the amount of protein. There are many fluorescent stains, including those of a non-
covalent variety such as SYPRO Orange, Red, Ruby, and Tangerine (Invitrogen, Carlsbad, 
CA, USA), ruthenium II, Deep Purple (GE Healthcare, Piscataway, NJ, USA), Krypton 
(Thermo Scientific, Inc., Rockford, IL, USA), and Oriole (Biorad, Hercules, CA, USA). The 
advantages are sensitivity, a greater dynamic range, and compatibility with mass 
spectrometry. Disadvantages lie primarily with cost, because of the necessity for extensive 
hardware for detection and quantification, the loss of signal with exposure to light, and the 
potential for masking certain peptides. For example, Deep Purple and SYPRO Ruby begin to 
lose their fluorescence after two minutes of exposure to UV transillumination, so that by 19 
minutes they have lost 83% and 44% of their fluorescence, respectively (Smejkal et al., 2004). 
SYPRO Ruby may also inhibit identification of cysteine- and tryptophan-containing 
peptides (Ball & Karuso, 2007). In addition, not all fluorescent stains are compatible with the 
various gel types that are used to fractionate proteins for LC-MS/MS. Ruthenium II, which 
is much cheaper than SYPRO stains, causes increased background staining in Bis-Tris gels 
relative to Tris-Glycine gels (Moebius et al., 2007). These are all factors to keep in mind as 
part of your experimental design. Finally, once the gel is stained, any vertical streaking of 
protein is likely the result of insufficient equilibration or problems with the buffer solution, 
whereas horizontal streaking may be the result of incomplete solubilization, impurities, 
improper detergent, or an isoelectric focusing time that is too long or too short. With the 
completion of staining, the gel will need to be destained prior to removal of gel spots either 
manually or with a robotic arm. 
4. Verification of protein partners 
4.1 Manual verification of peptides  
While the specifics of understanding how the data are obtained and analyzed are beyond 
the scope of this chapter, a quick review of some highlights are useful before describing 
potential experiments to validate your interactions. Once tandem mass spectrometry is 
completed you will obtain data derived from database search engines such as MASCOT, 
Seaquest, and X! Tandem. Search engines such as MASCOT generate scores as well as a 
compilation of spectral data. Scores above 60 can be considered valid for protein 
identification, assuming other parameters such as spectral data are in order. However, one 
may want to be conservative, especially when examining potential new partners. 
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Regardless, scores should not be taken at face value without analyzing the fragmentation 
spectra for each identified peptide, since you can have good scores and bad spectral data as 
well as bad scores and good spectral data. Personnel from your mass spectrometry core 
facility can assist in these analyses, however, you should familiarize yourself with how the 
ion spectra are generated and identified for your own understanding. A good starting point 
in comprehending spectral data is a tutorial at proteome software.com that comes in the 
form of a short presentation, http://www.proteomesoftware.com /Proteome_ 
software_pro_protein_ id.html. In addition, there are many other sources of value in 
understanding the mechanics of mass spectrometry-based proteomics, including light 
reading in review articles (Aebersold and Mann, 2003), as well as more intense reading in 
specialized books (Gross, 2004). Also, before deciding on a core facility to analyze your 
precious data, assuming you have a choice, you may want to give this sobering article a 
quick read (Bell et al., 2009). This paper will likely push your choice towards a facility where 
the personnel have a great amount of experience and the search engines are continually 
maintained and up-to-date. Finally, the data should be analyzed for false positive rates, 
since some proteomics journals now require these analyses, including Molecular and Cellular 
Proteomics, which published standards in 2005 (Bradshaw, 2005).  
4.2 Reciprocal coimmunoprecipitation 
Once you have obtained the results, showing the putative protein-protein interactions, you 
can use various means to begin assessing their validity using bioinformatics and different 
experimental procedures. Here, we will discuss some of the methods for experimentally 
verifying interactions as well as assessing the potential functions of these interactions. The 
methods to verify are many and can depend on the protein of interest as well as the 
experimental question. However, one of the first and relatively easy steps for verification, 
considering that you’ve just run a two-dimensional gel, is to perform a reciprocal 
coimmunoprecipitation. Here, the goal is to coimmunoprecipitate the protein that was 
originally used as bait (antigen) by using the newfound prey (protein partner). In essence, 
there is a role reversal, so that the former bait is now prey and vice-versa. The means to 
accomplish this procedure are similar to those used for a coimmunoprecipitation using 
western blotting. Once you step into the realm of probing the results of a 
coimmunoprecipitation experiment with an antibody in a western blot, you have to consider 
the IgG artifacts that may appear on your film. These artifacts are the result of the presence 
of light (~25 kDa) and heavy (~50 kDa) immunoglobulin fragments that are detected when 
using an antibody from the same species for both the immunoprecipitation 
/coimmunoprecipitation pull-down and the western blot. The secondary antibody will 
recognize both IgG chains, since these are eluted from the beads along with the antibody 
and fractionated on the gel. The consequence is that the antigen will be masked if it has a 
weight similar to either IgG. Moreover, if monoclonals are used to both pull down and 
probe the blot, the secondary recognizes the 25 kDa band; if polyclonals are used for both, 
the 50 kDa band will appear as artifact. A problematic example is the use of a rabbit 
polyclonal antibody for both the immunoprecipitation and the western blot. To circumvent 
this issue, you can use antibodies from different species or use a secondary antibody 
consisting of HRP bound to Protein A or G. An HRP conjugated to either of these proteins 
will detect their non-denatured forms but not their denatured forms (Lal et al., 2005). A 
third solution is to use secondary antibodies that only recognize the light or heavy chain 
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IgGs (Jackson Immunoresearch Laboratories, Inc., Westgrove PA, USA). Thus, if your 
protein of interest lies in the 45 - 55 kDa range, you would use a secondary that recognizes 
only the light chain IgG and vice versa, if your protein lies in the 20 to 30 kDa range. 
However, one assumption that should not be made in running the reciprocal 
coimmunoprecipitation is that all the parameters in washing and stringencies are the same 
as for the original coimmunoprecipitation. We find that at times these variables have to be 
tweaked slightly differently. However, with practice these issues are usually fixed relatively 
quickly.  
4.3 RNAi and overexpression 
A method of verification that can clarify the function of your newly discovered interactions 
is the use of RNAi in a heterologous expression system. This approach is especially useful 
for proteins that lend themselves well to this sort of system, such as ion channels. There are 
several different types of cells to use, including HEK 293 and CHO cells, and if cell polarity 
is of concern, Madin-Darby Canine Kidney (MDCK) epithelial cells. These expression 
systems provide a vehicle for, not only expressing your proteins, but also as a means to 
silence the protein endogenously.  
 
 
Fig. 3. Experiments, using cDNAs, are conducted to probe the function of protein-protein 
interactions when the prey protein is silenced in a heterologous expression system. (1) The 
original bait protein, in the form of an HA-tagged cDNA, is transfected with (2) siRNAs 
targeting specific nucleotides of the newly- discovered protein partner, or with scrambled 
RNAs (scRNAs; control) containing nonsense sequences. In this scenario, the (3) prey 
protein is endogenous to the expression system. Plates for each treatment are prepared in 
triplicate. (4) Cells from each treatment are scraped, homogenized and prepared for western 
blotting. (5) The resultant blot is probed for expression of the HA-tagged protein in both 
treatment and control conditions.  
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In order to accomplish these experiments, you will need the gene or genes that encode one 
or both of your proteins, that is, the bait and the prey. If the cDNA comes from either a 
private source or a vendor, do not assume that the construct you receive contains cDNA 
with a correct sequence. Be sure that it was sequenced very recently before use, as in, after 
the last amplification, because it is not uncommon to obtain constructs from either source 
only to discover a mutation during the course of your study, when it’s too late. Once 
sequenced, tag the cDNA on either the C- or N-terminus with one of the specified tags 
discussed previously. We typically find that the antibodies to the HA and FLAG tags work 
quite well in these experiments. However, you have to keep in mind that the tag itself may 
interfere with the interaction. If the coimmunoprecipitation fails, there is no need to panic, 
because you can just place the tag at the other end. Also, remember that if the tag is placed 
on the N-terminal end of a signaling protein, you may lose your tag. Inserting the tag farther 
into the construct resolves this issue.  
The decision then comes down to, when to silence and when to over-express, once all the 
necessary cDNA constructs are in order. In our work, we find that inserting and over-
expressing the cDNA, encoding the original bait protein, and silencing the partner (prey) 
with siRNAs endogenously, works the best in our RNAi experiments (Figure 3). This 
approach entails determining that the partner, pulled from the high-throughput study, is 
expressed endogenously in your heterologous system. If so, check that the sequences of the 
siRNAs match those of the endogenous protein found in the heterologous cells. Be sure to 
have at least three to four siRNAs, targeting 18 – 23 bases of the sequence in different 
regions that are approximately 70 – 100 bases from either the 5’ or 3’ ends. Search for AA 
dinucleotides, since siRNAs with an overhanging UU pair at the 3’ end is the most effective, 
although other dinucleotides are effective to some extent (Elbashir et al., 2001; Elbashir et al., 
2002). Avoid runs of G or C, since these are cut by RNAses. In addition, the GC content 
should not exceed 30 – 50% because the siRNA becomes less active. BLAST siRNA 
sequences to avoid knockdown of genes with similar sequences.  
Once all materials are ready, transfect the cells with the siRNAs and the over-expressed 
protein (Figure 3). A fluorescent tag such as Cerulean can be used to check for the earliest 
expression of protein in live cells. We find that proteins are expressed within the first two 
hours, with transfection reagents such as Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA), 
which can be removed after four hours of transfection. However, the efficiency of transfection 
may vary from cell type to cell type, so a test of comparable products is needed to find the 
most efficient one. Anywhere from one to all of the siRNAs can be added in an equivalent 
ratio. Following transfection, cells are allowed to grow for approximately 48 hours at which 
time they are processed for protein quantification. Run triplicate plates along with a negative 
control, such as cells treated with scrambled RNA and over-expressed protein. Experiments 
are repeated a total of three times. Band densities are measured, averaged, and analyzed for 
statistical significance by comparing experimental versus control groups. In order to control 
for protein loading, perform a protein assay and verify by analyzing a control protein on the 
same blot as experimental and control treatments (e.g., -actin, GAPDH).  
In a similar manner, over-expression of the partner can be managed through transfection of 
heterologous expression systems (Figure 4). Again, the bait protein can be measured, but 
this time in response to over-expressing the prey as opposed to silencing. Transfect both 
constructs in a 1:1 ratio and use a control, consisting of empty vector or vector with the 
construct in reverse sequence along with the construct carrying the prey sequence. This 
procedure will clarify if the addition of another vector dilutes the expression of the prey 
protein. Densitometry measurements are made as before and analyzed statistically.  
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In summary, the search for mechanisms that regulate the many proteins in different cell 
systems can be tackled using a variety of different techniques. The results can provide you 
with a bounty of data that can be verified and used to mine many different databases. The 
outcomes from these experiments will provide you with new and fascinating insights that, 
heretofore, you may not have thought about. The critical issues are that you will need to obtain 
a clear understanding of what is occurring to the proteins at different stages of the experiment. 
This understanding will allow you to obtain clean representations of the proteins to be 
assessed with fewer inherent artifacts. Once mass spectrometry is completed, the data can then 
be used to mine various databases in order to fit and expand your data into an interactome.  
 
 
Fig. 4. Experiments, using cDNAs, are conducted to probe the function of protein-protein 
interactions when the prey is over-expressed in a heterologous expression system. (1) The 
original bait with the (2) newly-discovered prey or the bait with plasmid containing the 
reverse sequence of the prey (control) are cotransfected into (3) CHO cells. (4) Cells are 
collected and prepared for western blotting, where expression of the bait protein is probed 
(5) for both treatment and control conditions.  
5. Bioinformatics 
5.1 Comparison of high-throughput data with existing data 
Once the initial experiments are completed, the lab worker will often wish to analyze the data 
by comparison to known interactions already existing in molecular interaction databases. 
These resources exist to collate and curate experimental data from laboratories around the 
world. Initially, interaction databases were established in isolation and often performed 
redundant curation of the same, high-visibility papers to their own standards, subsequently 
releasing the data in their own proprietary formats. However, more interaction data is 
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published in any one calendar month than can be captured by these resources collectively, and 
no single database can claim to have complete coverage of the literature. In order to approach 
a complete interactome for the organism or process of interest, the user has always had to 
combine data from multiple resources. This was well nigh impossible prior to 2004, as the 
different data formats, required separate parsers to be written for each data source. This 
approach began to change with the release of the first HUPO-PSI standard representation of 
interaction data. Nowadays, two related formats exist – PSI-MI XML2.5 and MITAB2.5 
(Kerrien et al., 2007), which are supported by both the majority of interaction databases and 
also by related visualization and analytical resources. These formats have enabled consistent 
data capture by multiple resources, with the choice of XML or tab-deliminated files often 
driven by either the complexity of data that the user wishes to harvest, or the amount of 
bioinformatic support available to them. Controlled vocabularies now make the terminology 
used to annotate these data consistent across the many data resources. 
One major advantage of multiple resources sharing the same data format is that it is now 
possible to simultaneously access multiple resources with a single query, cluster the results, 
and visualize these in a single graph. A PSI Common Query InterfaCe (PSICQUIC) was 
developed that allows software clients to interact with multiple services and is based on the 
existing PSI MI file formats and the new Molecular Interaction Query Language (MIQL) 
(Aranda et al., in preparation). MIQL is based on standard Lucene syntax 
(http://lucene.apache.org/) and offers single word or phrase queries (abl1 AND “pull 
down”), search in specific data attributes/columns (abl1 AND species:human), wildcards 
(abl*), and logical operators. At the time of writing, 16 data providers were providing 
PSICQUIC servers, with a total of 16 million interactions available to query. PSICQUIC lays 
no constraint on data type or quality and much of what is available is also redundant, in that 
databases, which do not have their own curation team, will import information from those 
that do. To address this issue, several of the major databases have come together to 
synchronize their curation rules and data release through the IMEx Consortium 
(www.imexconsortium.org). This consortium allows the user to access and download a non-
redundant, consistently annotated set of data, again using a PSICQUIC client to access 
appropriately tagged records (Orchard et al. in preparation). 
5.2 Data resources 
A number of databases exist, many of which have a bias in their curation strategy, either 
towards particular organisms or cellular processes. A brief summary of a number of these 
resources is given below, a more complete but less detailed list can be obtained from 
Pathguide (www.pathguide.org/). All the databases listed make their data available both 
through a dedicated website and also from their respective ftp sites in one or both of the PSI 
formats. 
IntAct (www.ebi.ac.uk/intact) – no species or process bias, collects data from all organisms. 
Mainly contains protein-protein interactions but also annotates protein-small molecule, 
protein-nucleic acid. Interactions are derived from literature curation or direct user 
submissions and are freely available. Database and associated tools are open-source and 
available for download. IntAct provides a PSICQUIC service and is a full member of IMEx. 
MINT (http://mint.bio.uniroma2.it/mint/) - no species or process bias, collects data from 
all organisms. Focuses on experimentally verified protein-protein interactions mined from 
the scientific literature. MINT provides a PSICQUIC service and is a full member of IMEx. 
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DIP (http://dip.doe-mbi.ucla.edu/dip) - no species or process bias, collects data from all 
organisms. Catalogs experimentally determined protein-protein interactions between 
proteins. The data are both manually curated and also automatically, using computational 
approaches that utilize knowledge about the protein-protein interaction networks extracted 
from the most reliable, core subset of the DIP data. DIP provides a PSICQUIC service and is 
a full member of IMEx. 
MatrixDB (http://matrixdb.ibcp.fr) - focuses on interactions established by extracellular 
proteins and polysaccharides, mainly in human and mouse. Reports interactions of proteins, 
individual polypeptide chains or multimers (permanent complexes) and carbohydrates. 
MatrixDB provides a PSICQUIC service and is a full member of IMEx. 
InnateDB (www.innatedb.ca/)- a database of the genes, proteins, experimentally-verified 
interactions and signaling pathways involved in the innate immune response of humans 
and mice to microbial infection. Integrates known interactions and pathways from major 
public databases together with manually-curated data. InnateDB provides a PSICQUIC 
service and is a full member of IMEx. 
MPIDB (http://jcvi.org/mpidb/) - collects physical microbial interactions manually 
curated from the literature or imported from other databases. MPIDB provides a PSICQUIC 
service and is a full member of IMEx. 
BioGrid (http://thebiogrid.org/) – a resource of protein–protein and genetic interactions 
for many model organism species. BioGRID provides a PSICQUIC service and is an 
observer member of IMEx. 
HPRD (www.hprd.org/) – a database of human interactions, mixed species interactions 
(e.g. human-mouse) are modeled to human. Commercial entities have to pay a fee to use the 
data, under a licensing arrangement. 
5.3 Data visualization 
Once the user has downloaded their required data from one or all of the listed resources, the 
next step is to combine the networks then import and overlay your own data. The tool of 
choice for this exercise is most commonly Cytoscape (www.cytoscape.org), a free software 
package for visualizing, modeling and analyzing molecular and genetic interaction 
networks. In Cytoscape, nodes representing biological entities, such as proteins or genes, are 
connected with edges representing pairwise interactions, such as experimentally determined 
protein–protein interactions. Nodes and edges can have associated data attributes 
describing properties of the protein or interaction. Cytoscape allows users to extend its 
functionality by creating or downloading additional software modules known as ‘plugins’. 
These plugins provide additional functionality in areas such as network data query, 
network data integration and filtering, attribute-directed network layout, Gene Ontology 
(GO) enrichment analysis and network motif functional module, protein complex or domain 
interaction detection. 
Network data can be imported into Cytoscape is several formats, including those of the PSI-
MI. To merge files in Cytoscape, the gene or protein identifier in the file must exactly match 
the corresponding Cytoscape node ID (or other Cytoscape attribute that has been previously 
loaded). If no matching identifiers are present, the situation can be corrected by loading an 
additional identifier into Cytoscape as a new node attribute. The ID mapping service 
supplied by UniProt (www.uniprot.org/) or by PICR (www.ebi.ac.uk/Tools/picr/) are 
recommended to achieve this correction. The Advanced Network Merge, a core Cytoscape 
plugin will allow network merging on the click of a single button. 
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Fig. 5. An interaction network as viewed in Cytoscape. 
5.4 Interolog mapping 
Large-scale PPI networks are only available for a limited number of model organisms, therefore, 
groups working on less well-studied organisms have to rely on network inference using the 
interolog concept originally introduced by Walhout et al. (2000). This concept combines known 
PPIs from one or more source species and orthology relationships between the source and 
target species to predict PPIs in the target species. There are a number of resources available 
which perform the orthology mapping Inparanoid (http://inparanoid.sbc. su.se/cgi-
bin/index.cgi) and Compara ( www.ensembl.org /info/docs/api/ compara/index.html) being 
probably the best known. Few tools exist for interolog mapping, however, two database 
resources exist in which this exercise has been pre-computed for the user; STRING 
(http://string-db.org/) transfers associations/interactions between several hundred organisms 
and InteroPORC (http://biodev.extra.cea.fr/interoporc/) for the fully sequenced organisms 
described in the Integr8 database (www.ebi.ac.uk/integr8). Both resources make the data 
available in PSI format and both have a PSICQUIC server. Additionally, the InteroPORC 
software is freely available for in-house use (Michaut et al. 2008). 
6. Conclusions  
The data generated from experiments that examine genes and proteins has increased 
logarithmically over the last 20 years, largely driven by recent advances in high-throughput 
technologies that examine proteins individually, as well as in complexes. High-throughput 
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protein studies that combine coimmunoprecipitations with 2-D gels have increased as a result 
of the higher quality of data obtained from mass spectrometry. The advent of these technologies 
has helped to fuel a need for the formation of many curated databases, such as those that 
capture molecular interactions. These molecular interactions databases are increasing their 
usefulness to the community by making their datasets available in a single, unified format. In 
addition, many are also linked in a unifying organization, such as the IMEx Consortium, which 
is ensuring that the user can download a non-redundant set of consistently annotated data. This 
means that the user now has a single point of entry from which to download data, and an 
increasing number of tools with which to subsequently analyze those data. 
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